TransMedics Group, Inc. - Common Stock (NQ:TMDX)

82.83 +3.04 (+3.81%)

Delayed Quote Updated: 12:27 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5% ↗

May 04, 2022

U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 04, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...

Via Benzinga

TransMedics Stock Skyrockets On Increased 2022 Guidance ↗

May 04, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 23, 2022

On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 04, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

TransMedics Group: Q1 Earnings Insights ↗

May 03, 2022

TransMedics Group (NASDAQ:TMDX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings TransMedics Group reported...

Via Benzinga

Earnings Outlook For TransMedics Group ↗

May 02, 2022

TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication ↗

April 28, 2022

TransMedics Group, Inc. (NASDAQ: TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart System in favour of use with organs from donors after...

Via Benzinga

Earnings Scheduled For May 3, 2022 ↗

May 03, 2022

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 06, 2022

Gainers

Via Benzinga

88 Biggest Movers From Yesterday ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher ↗

February 24, 2022

U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 24, 2022

Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...

Via Benzinga

Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6% ↗

February 24, 2022

U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

February 24, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Recap: TransMedics Group Q4 Earnings ↗

February 23, 2022

TransMedics Group (NASDAQ:TMDX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

TransMedics Reports Positive Data From OCS DCD Heart Trial ↗

November 04, 2021

TransMedics Group Inc (NASDAQ: TMDX) has announced topline results from its OCS donors after circulatory death (DCD) Heart Trial. Related: TransMedics' OCS Heart...

Via Benzinga

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

TransMedics' OCS Heart System Scores FDA Approval ↗

September 07, 2021

TransMedics Group Inc (NASDAQ: TMDX) has received FDA premarket approval (PMA) for its OCS Heart system. Related content: Benzinga's Full FDA...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 07, 2021

Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...

Via Benzinga

Looking into TransMedics Group's Return on Capital Employed ↗

August 30, 2021

Pulled from Benzinga Pro data TransMedics Group (NASDAQ:TMDX) reported Q2 sales of $8.17 million. Earnings fell to a loss of $9.87 million, resulting in a 51.65% decrease from...

Via Benzinga

Earnings Scheduled For August 5, 2021 ↗

August 05, 2021

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

50 Biggest Movers From Friday ↗

July 19, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 41.2% to settle at $7.10 on Friday. Blue Foundry Bancorp (NASDAQ: BLFY) gained 29% to close at $12.90 after the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 15, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 13.66% to $1.58 during Thursday's pre-market session. The market value of their outstanding shares is at $63.3...

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.